万向节机头放疗系统:实时监测动态肿瘤追踪与Dynamic WaveArc的兴衰
本文综述了工业界与学术界合作开发的万向节机头放疗装置,该装置于2008年进入临床应用,具备多影像引导功能,由此衍生出实时监测动态肿瘤追踪放疗(DTTRM)和Dynamic WaveArc(DWA)两种新模式。DTTRM已用于肺癌和肝肿瘤的立体定向体部放疗(SBRT)及胰腺癌的调强放疗(IMRT);DWA在前列腺癌、乳腺癌和颅底肿瘤中初步显示了临床价值。该系统于2016年因商业决策终止上市。
要点
- DTTRM可在不延长治疗时间的前提下实现四维放疗,已临床用于肺癌、肝肿瘤SBRT及胰腺癌IMRT。
- DWA通过机架与机环同步旋转联合动态多叶准直器优化,实现非共面个体化计划。
- 该系统2016年因商业决策终止销售,但其研发经验对放疗新技术开发有借鉴意义。
核心结论
- 万向节机头放疗系统虽于2016年终止上市,但其衍生的DTTRM与DWA两种治疗模式已初步显示临床可行性。
- DTTRM与DWA分别在日本国家资助下开展前瞻性临床试验。
研究设计与样本
- 本文为综述,总结万向节机头放疗装置的研发与成就,重点聚焦DTTRM与DWA。
- 该装置由工业界与学术界合作开发,概念为兼顾稳健结构与高灵活性,2008年开始临床应用。
主要发现
- DTTRM实现了不延长放疗时间的四维放疗,临床上已用于肺癌和肝肿瘤的SBRT以及胰腺癌的IMRT。
- DWA通过机架-机环同步旋转与动态多叶准直器优化结合,发挥SBRT系统的非共面多功能性。
- DWA可创建患者个体化治疗计划,在保持剂量学稳健递送的同时为危及器官保护提供额外灵活性。
- DWA的临床实用性已在前列腺癌、乳腺癌和颅底肿瘤中初步显示。
临床怎么用
- DTTRM可用于肺癌、肝肿瘤的SBRT及胰腺癌IMRT,在不延长治疗时间的前提下实施四维放疗。
- DWA可用于前列腺癌、乳腺癌和颅底肿瘤的个体化非共面治疗计划设计,以增加危及器官保护的灵活性。
局限性
- 该系统于2016年因商业决策终止市场推广,相关前瞻性临床试验仍在进行中。
- DWA的临床实用性仅为初步显示,尚待前瞻性临床试验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A gimbaled-head radiotherapy device was developed by industry-academic collaborations, with a concept of robust structures whilst maintaining high flexibilities, and its clinical application started in 2008. The unique structures with multi-image guidance functions initiated 2 new treatment modalities. One is dynamic tumor tracking radiotherapy with real time monitoring (DTTRM), which enables 4-D radiotherapy without prolongation of radiotherapy treatment time. This treatment has become clinically feasible for stereotactic body radiotherapy (SBRT) of lung cancers and liver tumors, and intensity-modulated radiotherapy (IMRT) for pancreatic cancers. The second one is Dynamic WaveArc therapy (DWA), the non-coplanar versatility of the SBRT system by combining the gantry-ring synchronized rotation with dynamic multileaf collimator optimization. DWA opens the possibility to create patient-individualized treatment plans, allowing additional flexibility in organ at risk sparing while preserving dosimetric robust delivery. The clinical usefulness of the DWA has been preliminary shown for those tumors in the prostate, breast and skull base. Prospective clinical trials are under way with a support of the national funding of Japan for DTTRM and DWA, respectively. Marketing of the system was terminated in 2016 due to a commercial decision. However, lessons can be learned from the development process of this device that might be useful for those who have interests in new technologies and clinical applications in radiation oncology. This review article aims to summarize the developments and achievements of a gimbaled-head radiotherapy device with a focus on DTTRM and DWA.
引用
- Hiraoka M, Mizowaki T, Matsuo Y, et al. The gimbaled-head radiotherapy system: Rise and downfall of a dedicated system for dynamic tumor tracking with real-time monitoring and dynamic WaveArc. Radiother Oncol. 2020. PMID: 32659250. doi:10.1016/j.radonc.2020.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。